PharmaTutor (December - 2017)
ISSN: 2347 - 7881
(Volume 5, Issue 12)
Received On: 15/08/2017; Accepted On: 18/08/2017; Published On: 01/12/2017
AUTHORS:
Devender Sharma*, Satish Kosalge, Snehal R. Dixit
Department of Pharmaceutics,
Hi – Tech college of pharmacy,
Chandrapur, Maharashtra, India
*sdevender350@gmail.com
ABSTRACT:
Aging is one of the phases of individual’s life span, which everyone wants to escape. The process of aging is much more a social phenomena than biological phenomena. Aging brings many changes such as, loss of eyesight, hearing loss, dementia, e tc. Aging may give rise to diseased states such as, heart disease, cancer, cerebrovascular disease (relating to blood vessels that supply the brain), pneumonia and flu, and chronic obstructive pulmonary diseases. The key - factor behind aging is the GDF11, i .e., Growth and Differentiation factor - 11. GDF11 is also known as Bone Morphogenetic Factor - 11 (BMP11). It is termed as key circulating ‘anti - aging’ factor. GDF11 is expressed in wide range of tissues and has been shown to play important roles in developme nt of olfactory system, retina and pancreas. It functions in regulating anterior - posterior patterning of the axial skeleton muscle system. Scientists theorize that aging likely results from a combination of many factors viz., Lifestyle, Diseases and Genes. GDF11 is essential for mammalian development and has been suggested to regulate aging of multiple tissues, whereas myostatin is a well - described negative regulator of postnatal skeletal and cardiac muscle mass and modulates metabolic processes.
How to cite this article: Sharma D, Kosalge S, Dixit SR;Influence of GDF-11 in Aging Process : An Review; PharmaTutor; 2017; 5(12); 18-29
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Aaron C. Hinken, Janine M. Powers, Guizhen Luo, Jason A, Holt, Andrew N Billin and Alan J. Russel, “Lack of evidence for GDF11 as a rejuvenator of aged skeletal muscle satellite cells”, Aging Cell; 2016 (15), pg. no.: 582-584.
2. Tommaso Poggioli, Ana Vujic, Peiguo Yang, Claudio Macias; “Circulating Growth Differentiation Factor 11/8 Levels Decline with Age”, Circulatory Research; October2015; CIRCRESAHA.115.3075521.
3. Ge G, Hopkins DR, Ho WB, Greenspan DS (Jul 2005). "GDF11 forms a bone morphogenetic protein 1-activated latent complex that can modulate nerve growth factor-induced differentiation of PC12 cells". Molecular and Cellular Biology. 25 (14): 5846–58.. "Recombinant-Human GDF11".
4. Sinha M, Jang YC, Oh J, Khong D, Wu EY, Manohar R, Miller C, Regalado SG, Loffredo FS, Pancoast JR, Hirshman MF, Lebowitz J, Shadrach JL, Cerletti M, Kim MJ, Serwold T, Goodyear LJ, Rosner B, Lee RT, Wagers AJ (May 2014). "Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle". Science. 344(6184): 649–52. doi:10.1126/science.1251152. PMID 24797481.
5. Katsimpardi L, Litterman NK, Schein PA, Miller CM, Loffredo FS, Wojtkiewicz GR, Chen JW, Lee RT, Wagers AJ, Rubin LL (May 2014). "Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors". Science. 344 (6184): 630–4.
6. Egerman MA, Cadena SM, Gilbert JA, Meyer A, Nelson HN, Swalley SE, Mallozzi C, Jacobi C, Jennings LL, Clay I, Laurent G, Ma S, Brachat S, Lach-Trifilieff E, Shavlakadze T, Trendelenburg AU, Brack AS, Glass DJ (Jul 2015). "GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration". Cell Metabolism. 22 (1): 164–74.doi:10.1016/j.cmet.2015.05.010. PMID 26001423.
7. Age-reversal effects of 'young blood' molecule GDF-11 called into question, retrieved20 May 2015
8. 'Young blood' anti-ageing mechanism called into question, retrieved 20 May 2015
9. Smith SC, Zhang X, Zhang X, Gross P, Starosta T, Mohsin S, Franti M, Gupta P, Hayes D, Myzithras M, Kahn J, Tanner J, Weldon SM, Khalil A, Guo X, Sabri A, Chen X, MacDonnell S, Houser SR (Nov 2015). "GDF11 Does Not Rescue Aging-Related Pathological Hypertrophy". Circulation Research. 117 (11): 926–32.
10. Andersson O, Reissmann E, Ibáñez CF (Aug 2006). "Growth differentiation factor 11 signals through the transforming growth factor-beta receptor ALK5 to regionalize the anterior-posterior axis". EMBO Reports. 7 (8): 831–7.
11. McPherron AC, Lee SJ (Nov 1997). "Double muscling in cattle due to mutations in the myostatin gene". Proceedings of the National Academy of Sciences of the United States of America. 94 (23): 12457–61.
12. Lee SJ, McPherron AC (Oct 1999). "Myostatin and the control of skeletal muscle mass".Current Opinion in Genetics & Development. 9 (5): 604–7.
13. V. Kh. Khavinsona, b, d, B. I. Kuznikc, S. I. Tarnovskayab, and N. S. Linkovaa, “GDF11 Protein as a Geroprotector” ; ISSN 2079-0864; Biology Bulletin Reviews;2016; vol. 6(2); 141-148.
14. 15. Ryan G. Walker, Tommaso Poggioli, Lida Katsimpardi; December 2016, “Biochemistry and B iology of GDF11 and Myostatin”, Circulation Research,Pg. no.: 1125-1142
15. Recombinanat Human/Mouse/Rat; GDF11/ BMP11; R & D Systems- a biotechne brand; Catalog no. 1958-GD; October 2015.
16. Ferenc Jeanplong, Shelley J. Falconer; “GDF-11 is developmentally regulated in skeletal muscle and inhibits myoblast differentiation”, OJMIP; 2012 (20); Pg. no.: 127-128.
17. Yun- Sil Lee and Se-Jin Lee; “ Regulation of GDF11 and Myostatin activity by GASP1 and GASP2”, Dept. of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, MD 21205; PNAS; 2013; Page No. 3713-3722.
18. Medical Press- “Functioning of aged Brains and Muscles in mice made younger”, Harvard University; May 2014.
19. Gamer, L.W. et al. (1999) Dev. Biol. 208: 222
20. Nakashima, M. et al. (1999) Mech. Dev. 80:185.
21. Gad, J.M. and P.P.L. Tam (1999) Curr. Biol. 9:R783.
22. McPherron, A.C. et al. (1999) Nat. Genet. 22:260.
23. McPherron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387(6628):83–90.
24. NakashimaM,ToyonoT,AkamineA,JoynerA(1999)Expressionofgrowth/differentiation factor 11, a new member of the BMP/TGFbeta superfamily during mouse embryogenesis. Mech Dev 80(2):185–189.
25. Wu HH, et al. (2003) Autoregulation of neurogenesis by GDF11. Neuron 37(2): 197–207.
26. Kim J, et al. (2005) GDF11 controls the timing of progenitor cell competence in developing retina. Science 308(5730):1927–1930.
27. Harmon EB, et al. (2004) GDF11 modulates NGN3+ islet progenitor cell number and promotes beta-cell differentiation in pancreas development. Development 131(24): 6163–6174.
28. Dichmann DS, Yassin H, Serup P (2006) Analysis of pancreatic endocrine development in GDF11-deficient mice. Dev Dyn 235(11):3016–3025.
29. McPherron AC, Lawler AM, Lee SJ (1999) Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11. Nat Genet 22(3):260–264.
30. Souza TA, et al. (2008) Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators. Mol Endocrinol 22(12):2689–2702.
31. Loffredo FS, et al. (2013) Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell 153(4):828–839.
32. Lee SJ (2004) Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol 20: 61–86.
33. Hill JJ, Qiu Y, Hewick RM, Wolfman NM (2003) Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: A novel protein with protease inhibitor and follistatin domains. Mol Endocrinol 17(6):1144–1154.
34. Trexler M, Bányai L, Patthy L (2002) Distinct expression pattern of two related human proteins containing multiple types of protease-inhibitory modules. Biol Chem 383(1): 223–228. 36. Trexler M, Bányai L, Patthy L (2001) A human protein containing multiple types of protease-inhibitory modules. Proc Natl Acad Sci USA 98(7):3705–3709.
35. Kondás K, Szláma G, Trexler M, Patthy L (2008) Both WFIKKN1 and WFIKKN2 have high affinity for growth and differentiation factors 8 and 11. J Biol Chem 283(35): 23677–23684.
36. Szláma G, Kondás K, Trexler M, Patthy L (2010) WFIKKN1 and WFIKKN2 bind growth factors TGFβ1, BMP2 and BMP4 but do not inhibit their signalling activity. FEBS J 277(24):5040–5050.
37. Haidet AM, et al. (2008) Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors. Proc Natl Acad Sci USA 105(11):4318–4322.
38. Monestier O, et al. (2012) Ubiquitous Gasp1 overexpression in mice leads mainly to a hypermuscular phenotype. BMC Genomics 13(1):541.
39. Esquela, A.F. and S.J. Lee (2003) Dev. Biol. 257:356.
40. Oh, S.P. et al. (2002) Genes & Dev. 16:274.
41. Loffredo, F.S. et. al. (2013) Cell. 153.828.
42. Katsimpardi, L. et. al. (2014) Science (ahead of print).
43. Sinha, M. et. al. (2014) Science (ahead of print).
44. Loffredo FS, Steinhauser ML, Jay SM, Gannon J, Pancoast JR, Yalamanchi P, Sinha M, Dall'Osso C, Khong D, Shadrach JL, Miller CM, Singer BS, Stewart A, Psychogios N, Gerszten RE, Hartigan AJ, Kim MJ, Serwold T, Wagers AJ, Lee RT (May 2013). "Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy". Cell. 153 (4): 828–39.
45. Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A. 2001;98:9306–9311
46. Andersson O, Reissmann E, Jörnvall H, Ibáñez CF. Synergistic interac- tion between Gdf1 and Nodal during anterior axis development. Dev Biol. 2006;293:370–381.
47. Rebbapragada A, Benchabane H, Wrana JL, Celeste AJ, Attisano L. Myostatin signals through a transforming growth factor beta-like signal- ing pathway to block adipogenesis. Mol Cell Biol. 2003;23:7230–7242.
48. Tommaso Poggioli, Ana Vujic, Peiguo Yang; “Circulating Growth and Differentiation 11/8 levels Decline with age”, Circulation Research: Jan. 2017; Pg. no. 1-14.
49. Helen Thomson, “Young Blood Turns Back Time”, New Scientists, 23 August 2014; Pg. no. 8-9.
50. Marc A. Egerman, Samael M. Cadena, Jason A. Gilbert; “GDF11 increases with age and inhibits Skeletal MuscleRegeneration”, Cell Metabolism 22; July 2015; 164-174.
51. Gene Cards; Human Gene Database; Life Map Science.
52. American Psycological Association- Older Adult’s Health and Age –Related Changes: Reality Versus Myth.
53. GDF11 growth differentiation factor 11 [ Homo sapiens (human) ]. Gene ID: 10220, updated on 18-Dec-2016.
54. Dr. Nascher et. al. ;Geriatrics: The Diseases of Old Age and their Treatment; 1990.
55. Bowen, Richard L.; Atwood, Craig S. (2004). "Living and Dying for Sex".Gerontology. 50 (5): 265–90.
56. Dillin A, Gottschling DE, Nyström T (2014). "The good and the bad of being connected: the integrons of aging". Curr Opin Cell Biol. 26: 107–12.
57. Jump up to:a b Truscott RJ (2009). "Presbyopia. Emerging from a blur towards an understanding of the molecular basis for this most common eye condition". Exp Eye Res. 88 (2): 241–7.
58. Pathai, S; Shiels, PG; Lawn, SD; Cook, C; Gilbert, C (March 2013). "The eye as a model of ageing in translational research--molecular, epigenetic and clinical aspects.". Ageing research reviews. 12 (2): 490–508.
59. Vary JC, Jr (November 2015). "Selected Disorders of Skin Appendages--Acne, Alopecia, Hyperhidrosis.". The Medical clinics of North America. 99 (6): 1195–211.doi:10.1016/j.mcna.2015.07.003. PMID 26476248
60. Takahashi, TA; Johnson, KM (May 2015). "Menopause.". The Medical clinics of North America. 99 (3): 521–34.
61. Thomas, Elaine; Peat, George; Croft, Peter (2014). "Defining and mapping the person with osteoarthritis for population studies and public health". Rheumatology 53(2):338 345. doi:10.1093/rheumatology/ket346.
62. "Hearing Loss and Older Adults" (Last Updated June 3, 2016). National Institute on Deafness and Other Communication Disorders. Retrieved September 11, 2016
63. "Facts About Cataract". September 2015. Retrieved 14 August 2016.
64. Fried, LP; Tangen, CM; Walston, J; Newman, AB; Hirsch, C; Gottdiener, J; Seeman, T; Tracy, R; Kop, WJ; Burke, G; McBurnie, MA (Mar 2001).
65. Frailty in older adults: evidence for a phenotype". The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 56 (3): M146–56.
66. Percentage derived from Table 2 in Fried et al. 2001
67. Wang JC, Bennett M (2012). "Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence". Circ Res. 111 (2): 245–59.
68. Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S (2016). "Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease". Circ Res. 118 (4): 535–46.
69. https://www.heart.org/idc/groups/ahamah-public/@wcm/@sop/@smd/documents/downloadable/ucm_ 470704.pdf
70. Larson, EB; Yaffe, K; Langa, KM (12 December 2013). "New insights into the dementia epidemic.". The New England Journal of Medicine. 369 (24): 2275–7.doi:10.1056/nejmp1311405. PMID 24283198
71. Schaie, K. Warner (2005). Developmental Influences on Adult Intelligence. doi:10.1093/acprof:oso/ 9780195156737.001.0001. ISBN 978-0-19-515673-7
72. pmhdev (25 March 2015). "Infertility: Overview" – via www.ncbi.nlm.nih.gov
74. "Mitochondrial Theory of Aging and Other Aging Theories". 1Vigor. Retrieved4 October 2013.
75. Jin, Kunlin (2010). "Modern Biological Theories of Aging.". Aging Dis. 1 (2): 72–74.
76. Guarente, Leonard P.; Partridge, Linda; Wallace, Douglas C. (2008). Molecular Biology of Aging. New York: Cold Spring Harbor. pp. 347–362. ISBN 978-0-87969-824-9
77. Gensler, Helen L.; Bernstein, Harris (1981). "DNA Damage as the Primary Cause of Aging". The Quarterly Review of Biology. 56 (3): 279–303. doi:10.1086/412317.JSTOR 2826464. PMID 7031747.
78. Sinha, Jitendra Kumar; Ghosh, Shampa; Swain, Umakanta; Giridharan, Nappan Veethil; Raghunath, Manchala (2014). "Increased macromolecular damage due to oxidative stress in the neocortex and hippocampus of WNIN/Ob, a novel rat model of premature aging".Neuroscience. 269: 256–64.
79. Freitas, Alex A.; De Magalhães, João Pedro (2011). "A review and appraisal of the DNA damage theory of ageing". Mutation Research/Reviews in Mutation Research. 728 (1–2): 12–22.
80. Strehler, Bernard L. (1986). "Genetic instability as the primary cause of human aging".Experimental Gerontology. 21 (4–5): 283–319.
81. Gaoxiang Ge, Delana R, Hopkins, Wen-Bin ; “GDF11 Forms a Bone Morphogenetic Protein 1-Activated Latent Complex That Can Modulate Nerve Growth Factor-Induced Differentiation of PC12 Cells; Molecular and Cellular Biology 25(14):5846-58 • August 2005.
82. Harmon EB, Apelqvist AA, Smart NG, Gu X, Osborne DH, Kim SK (Dec 2004). "GDF11 modulates NGN3+ islet progenitor cell number and promotes beta-cell differentiation in pancreas development". Development. 131 (24): 6163-74
83. Hartz, P. A. Personal Communication. Baltimore, Md. 2/3/2015.
84. Tsuda, T., Iwai, N., Deguchi, E., Kimura, O., Ono, S., Furukawa, T., Sasaki, Y., Fumino, S., Kubota, Y. PCSK5 and GDF11 expression in the hindgut region of mouse embryos with anorectal malformations. Europ. J. Pediat. Surg. 21: 238-241, 2011.
85. Esquela AF, Lee SJ (May 2003). "Regulation of metanephric kidney development by growth/differentiation factor 11". Developmental Biology. 257 (2): 356–70.
86. Gamer LW, Cox KA, Small C, Rosen V (Jan 2001). "Gdf11 is a negative regulator of chondrogenesis and myogenesis in the developing chick limb". Developmental Biology. 229(2): 407–20. doi:10.1006/dbio.2000.9981. PMID 11203700.
87. Kaiser J (Oct 2015). "Antiaging protein is the real deal, Harvard team claims".Science.
88. Jin K., “Modern Biological Theories of Aging”, Aging and Disease; 2010. 1(2): 72-74
.png)
